Skip to main content
Mahvish Muzaffar, MD, Oncology, Greenville, NC

MahvishMuzaffarMD

Oncology Greenville, NC

Hematologic Oncology

Associate Professor Program Director Hematology Oncology Fellowship Brody School of Medicine/East Carolina University

Dr. Muzaffar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Muzaffar's full profile

Already have an account?

  • Office

    524 Moye Blvd, Greenville, NC 27834
    Vidant Cancer Care at the Eddie and Jo Allison Smith Tower in Greenville
    Greenville, NC 27834
    Phone+1 252-816-2273

Education & Training

  • University of Toledo
    University of ToledoFellowship, Hematology and Medical Oncology, 2011 - 2013
  • University of Toledo
    University of ToledoResidency, Internal Medicine, 2008 - 2011
  • Alma Atinskij Med Inst
    Alma Atinskij Med InstClass of 1998

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2025
  • OH State Medical License
    OH State Medical License 2008 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Metastatic pattern and tumor sidedness in colorectal cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • How Coronavirus Changed Our Health Behaviors
    How Coronavirus Changed Our Health BehaviorsNovember 2nd, 2020
  • Greenville Doctors Give Breast Cancer Screening Advice
    Greenville Doctors Give Breast Cancer Screening AdviceOctober 28th, 2016
  • Outcomes Poorer for Black Patients with Early Breast Ca -Five-year disease-specific survival 94% vs 99% for whites
    Outcomes Poorer for Black Patients with Early Breast Ca -Five-year disease-specific survival 94% vs 99% for whitesAugust 9th, 2020
  • Join now to see all

Professional Memberships